Fertility Preservation Before Blood Cancer Treatment: What You Need to Know

A blood cancer diagnosis can feel like the ground shifting beneath you — and in the urgency to start treatment, it is easy for important conversations to fall through the cracks. One of the most time-sensitive is fertility preservation before blood cancer treatment. Many chemotherapy regimens, radiation protocols, and stem cell transplants can affect your ability to have biological children, but if the conversation happens early enough, there are options that can protect that possibility for the future.

According to the American Society of Clinical Oncology, oncologists should discuss the risk of treatment-related infertility with all patients of reproductive age as early as possible — ideally before treatment begins. Yet research shows that while roughly 80 percent of young adult cancer patients are told treatment may affect their fertility, only about half receive information about specific preservation methods. This guide is meant to help close that gap.

Why Blood Cancer Treatment Can Affect Fertility

Chemotherapy works by targeting rapidly dividing cells — and reproductive cells are among the most active in the body. Eggs in the ovaries and sperm-producing cells in the testes are particularly vulnerable to the same mechanisms that make chemotherapy effective against cancer. The degree of risk depends on several factors: the specific drugs used, the total dose, the patient's age, and baseline reproductive health.

Among blood cancer treatments, alkylating agents such as cyclophosphamide, busulfan, and melphalan carry the highest risk of gonadal damage. Regimens that combine multiple alkylating agents, or that use high cumulative doses, increase the risk further. In contrast, regimens like ABVD — commonly used for Hodgkin lymphoma — are associated with a lower risk of long-term infertility. Radiation therapy directed at or near the pelvis, as well as stem cell transplant conditioning regimens, also carry significant fertility risk.

Research published in the journal Cancers found that approximately 21 percent of adult women and 45 percent of adult men treated for Hodgkin lymphoma experienced presumed infertility after treatment. The numbers vary by diagnosis and regimen, but the takeaway is clear: fertility risk is real, it is common, and it deserves a conversation before treatment starts.

Fertility Preservation Options for Men and Boys

For men and adolescent boys who have reached puberty, sperm banking is the most established and widely available preservation method. The process involves collecting and freezing sperm samples before treatment begins. It is noninvasive, can typically be completed within a few days, and is relatively affordable compared to other preservation techniques — averaging around $745 for the first year, including collection and storage.

For prepubertal boys who are not yet producing mature sperm, testicular tissue cryopreservation is an emerging option being studied at specialized centers. This involves surgically removing and freezing a small piece of testicular tissue with the hope that future techniques will allow it to be used for reproduction. While still considered experimental, it may be the only option for very young patients facing highly gonadotoxic treatment.

Fertility Preservation Options for Women and Girls

For women, preservation options are more involved but have advanced significantly in recent years:

• Egg freezing (oocyte cryopreservation) — Eggs are retrieved after a course of hormonal stimulation and frozen for future use. This typically takes 10 to 14 days and is now considered a standard, non-experimental procedure. The average cost of an egg freezing cycle in the United States exceeds $10,000, though growing insurance coverage is helping reduce out-of-pocket costs.
• Embryo cryopreservation — Similar to egg freezing, but retrieved eggs are fertilized with sperm before being frozen as embryos. This option requires a sperm source (partner or donor) and has a long track record of success.
• Ovarian tissue cryopreservation — A portion of ovarian tissue is surgically removed and frozen before treatment. After treatment, the tissue can be transplanted back to restore both fertility and hormone production. This option is particularly important for prepubertal girls or patients who cannot delay treatment for egg retrieval.
• Ovarian suppression — Medications called GnRH agonists can temporarily suppress ovarian function during chemotherapy, which may help protect the ovaries from treatment damage. Research suggests this approach can reduce the impact on future ovarian function, though it is typically used alongside other preservation methods rather than as a sole strategy.

The Time Factor: Why This Conversation Cannot Wait

One of the most challenging aspects of fertility preservation in blood cancer is timing. Unlike some solid tumors where there may be weeks between diagnosis and treatment, blood cancers — particularly acute leukemias — often require treatment to begin within days. That narrow window makes it essential for the fertility conversation to happen at or very near the time of diagnosis.

Sperm banking can often be completed quickly, sometimes in a single visit. Egg freezing requires more lead time due to the hormonal stimulation cycle, but some oncologists and reproductive endocrinologists have developed rapid-start protocols that can shorten the timeline. Your oncology team can help assess whether a brief delay for preservation is safe given your specific diagnosis.

Questions to Ask Your Care Team

Bringing a list of questions to your oncologist can help make sure fertility is addressed early. Consider asking:

1. Does my specific treatment regimen carry a risk of infertility? How high is that risk?
2. Is there time to pursue fertility preservation before treatment starts?
3. Can you refer me to a reproductive endocrinologist or fertility specialist who works with cancer patients?
4. Which preservation options are most appropriate for my situation?
5. Will my insurance cover any portion of fertility preservation? Are there financial assistance programs available?
6. If preservation is not possible before treatment, are there any steps we can take during or after treatment to protect my fertility?

Financial Considerations and Growing Coverage

Cost has historically been one of the biggest barriers to fertility preservation for cancer patients. However, the landscape is changing. A growing number of states now mandate insurance coverage for medically indicated fertility preservation when a diagnosed condition or its treatment may cause iatrogenic infertility. As of 2026, several states require coverage for fertility retrieval and preservation services for cancer patients, with additional states considering similar legislation.

Organizations like RESOLVE: The National Infertility Association and the Leukemia & Lymphoma Society maintain up-to-date information about financial resources and state-by-state coverage requirements. Some fertility clinics also offer discounted rates or payment plans for oncology patients, so it is worth asking about financial options early in the process.

The Emotional Side of Fertility and Cancer

It is completely normal to feel overwhelmed by having to think about future family planning in the middle of a cancer diagnosis. Some patients feel certain they want to preserve their options; others are unsure whether they want children at all. Both responses are valid, and there is no single right answer.

What matters most is having the information and the opportunity to make the choice on your terms — rather than having the decision made for you by a treatment that could have been preceded by a conversation. Many cancer centers have social workers, patient navigators, or psychologists who can support you through this decision-making process. You do not have to figure it out alone.

Removing Barriers So You Can Focus on What Matters

Navigating a blood cancer diagnosis means managing dozens of decisions at once — treatment plans, appointments, side effects, and the everyday bills that do not pause just because your life has. When financial stress from non-medical expenses starts to compete with decisions about your care and your future, something has to give.

The Live Like Brent Foundation Comfort Fund helps blood cancer patients overcome non-medical barriers to treatment by paying approved expenses directly to the company or organization providing the service — things like utility bills, rent, transportation to treatment, lodging, and food support. When those everyday burdens are lifted, patients and families can direct their energy toward the decisions that shape their future.

If you or someone you love is facing a blood cancer diagnosis, your support helps remove the barriers that stand between patients and the care they need.